TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2018

Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.

Yasuo Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.